Myriad Genetics
MYGN
#7314
Rank
C$0.79 B
Marketcap
C$8.34
Share price
-5.88%
Change (1 day)
-8.32%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2023 (TTM): C-$4.08

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is C-$1.68. In 2022 the company made an earnings per share (EPS) of C-$1.96 a decrease over its 2021 EPS that were of C-$0.52.

EPS history for Myriad Genetics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$4.08108.64%
2022C-$1.96275.68%
2021C-$0.52-87.99%
2020C-$4.34755.56%
2019C-$0.51-194.74%
2018C$0.54-79.89%
2017C$2.66112.36%
2016C$1.25-35.97%
2015C$1.96-7.33%
2014C$2.11-37.24%
2013C$3.3759.33%
2012C$2.1120.97%
2011C$1.75-10.79%
2010C$1.9614.88%
2009C$1.7012.04%
2008C$1.52-454.1%
2007C-$0.43-42.45%
2006C-$0.75-8.62%
2005C-$0.82-18.88%
2004C-$1.0122.22%
2003C-$0.8225.81%
2002C-$0.65200%
2001C-$0.22-13.89%
2000C-$0.25-20.88%
1999C-$0.32-24.79%
1998C-$0.4361.33%
1997C-$0.26-34.21%
1996C-$0.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
C$3.81-327.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
C-$7.49 347.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$71.68 4,177.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C$11.73-800.00%๐Ÿ‡บ๐Ÿ‡ธ USA